BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17996602)

  • 1. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
    Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
    Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.
    Neubauer H; Li M; Kuehne-Heid R; Schneider A; Kaiser WA
    Br J Radiol; 2003 Jan; 76(901):3-12. PubMed ID: 12595319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
    Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
    J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
    Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
    J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of breast cancer: comparison of CT and MRI.
    Nakahara H; Namba K; Wakamatsu H; Watanabe R; Furusawa H; Shirouzu M; Matsu T; Tanaka C; Akiyama F; Ifuku H; Nakahara M; Tamura S
    Radiat Med; 2002; 20(1):17-23. PubMed ID: 12002599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings.
    Kawashima H; Kobayashi-Yoshida M; Matsui O; Zen Y; Suzuki M; Inokuchi M
    J Magn Reson Imaging; 2010 Nov; 32(5):1117-23. PubMed ID: 21031517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma.
    Schouten van der Velden AP; Boetes C; Bult P; Wobbes T
    Am J Surg; 2006 Aug; 192(2):172-8. PubMed ID: 16860625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Categorization of non-mass-like breast lesions detected by MRI.
    Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
    Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.